open access publication

Review, 2022

The Evolution of Geriatric Oncology and Geriatric Assessment over the Past Decade

Seminars in Radiation Oncology, ISSN 1053-4296, Volume 32, 2, Pages 98-108, 10.1016/j.semradonc.2021.11.002

Contributors

Outlaw D. Abdallah M. [1] Gil-Jr L.A. [2] Giri S. Hsu T. [3] Krok-Schoen J.L. [4] Liposits G. 0000-0002-8204-3949 [5] Madureira T. [6] Marinho J. [7] Subbiah I.M. [8] Tuch G. [9] Williams G.R. (Corresponding author)

Affiliations

  1. [1] Boston University School of Medicine
  2. [2] Universidade de São Paulo
  3. [NORA names: Brazil; America, South];
  4. [3] University of Ottawa
  5. [NORA names: Canada; America, North; OECD];
  6. [4] The Ohio State University College of Medicine
  7. [NORA names: United States; America, North; OECD];
  8. [5] Odense University Hospital
  9. [NORA names: Region of Southern Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD];

Abstract

Cancer is predominantly a disease of aging, and older adults represent the majority of cancer diagnoses and deaths. Older adults with cancer differ significantly from younger patients, leading to important distinctions in cancer treatment planning and decision-making. As a consequence, the field of geriatric oncology has blossomed and evolved over recent decades, as the need to bring personalized cancer care to older adults has been increasingly recognized and a focus of study. The geriatric assessment (GA) has become the cornerstone of geriatric oncology research, and the past year has yielded promising results regarding the implementation of GA into routine cancer treatment decisions and outcomes for older adults. In this article, we provide an overview of the field of geriatric oncology and highlight recent breakthroughs with the use of GA in cancer care. Further work is needed to continue to provide personalized, evidence-based care for each older adult with cancer.

Funders

  • National Cancer Institute
  • National Institutes of Health

Data Provider: Elsevier